Thursday, May 19, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | India To Produce 300mn Doses Of Sputnik V Vaccine In 2021 Report

India to produce 300mn doses of Sputnik V vaccine in 2021: Report

By IANS
Published: Published Date - 05:30 PM, Fri - 18 December 20
"In India, we have agreements with four large manufacturers. ...India will produce about 300 million doses or more of the vaccine for us next year," he was quoted as saying to Rossiya 24 TV channel by TASS news agency on Thursday.

Moscow: India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021, the head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said in an interview with a TV channel.

“In India, we have agreements with four large manufacturers. …India will produce about 300 million doses or more of the vaccine for us next year,” he was quoted as saying to Rossiya 24 TV channel by TASS news agency on Thursday.

RDIF is Russia’s sovereign wealth fund.

Dmitriev noted that out of 110 production sites that negotiated production of Sputnik V, RDIF chose 10 that meet its requirements.

“The Russian Sputnik V will be actively produced in the world and we see that this is built on a safe platform based on the human adenovirus,” Dmitriev said.

Earlier Dmitriev said that production of Sputnik V began in other countries, in particular in India, Korea, Brazil, and China.

Registered by Russia on August 11, Sputnik V became the world’s first coronavirus vaccine.

The vaccine was developed by the Gamaleya National Research Center of Epidemiology and Microbiology.

Its post-registration trials began in Moscow on September 7, with volunteers receiving the first vaccine on September 9.

A total of 40,000 people are involved in the programme.

RDIF supports the development of Russia’s Covid-19 vaccine by the Gamaleya Center and is investing in mass production of the vaccine by RDIF portfolio companies.

  • Follow Us :
  • Tags
  • Corona Virus Deaths
  • Coronavirus
  • Coronavirus in India
  • Coronavirus Latest Updates

Related News

  • CM KCR embarks on ‘national mission’

  • I want to dedicate this victory to all Indians: Telangana’s Nikhat Zareen

  • Working women face accommodation problem in Hyderabad

  • 17.89 lakh acres to be cultivated in erstwhile Warangal

  • Telangana’s employment rate rebounds post Covid-19

  • Job aspirants clarify doubts on various aspects of recruitment tests at NT, TT’s awareness program

Latest News

  • Opinion: Life within Dark Media

    2 hours ago
  • Editorial: Go beyond optics

    2 hours ago
  • ‘Credibility’ crisis hits Almas Global

    2 hours ago
  • 15-year-old Hyderabadi encourages students to use old textbooks to save trees

    2 hours ago
  • IPL 2022: Kohli’s 73 helps RCB beat GT to stay alive in playoff race

    3 hours ago
  • Hyderabad-based Intellixaa acquires yourcvwriter.com

    3 hours ago
  • Dalit Bandhu role model for the nation: Vinod Kumar

    3 hours ago
  • Tomato turns costly on tight supply in Hyderabad

    3 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam